Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Jan;130(1):83-6.
doi: 10.1001/archotol.130.1.83.

Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma: a comparison

Fernanda C Grizzo de Sampaio Góes  1 , Denise Tostes Oliveira, Regina Garcia Dorta, Inês Nobuko Nishimoto, Gilles Landman, Luiz Paulo Kowalski
Affiliations
Comparative Study

Prognoses of oral basaloid squamous cell carcinoma and squamous cell carcinoma: a comparison

Fernanda C Grizzo de Sampaio Góes et al. Arch Otolaryngol Head Neck Surg. 2004 Jan.

Abstract

Objective: To compare clinical and prognostic features in patients with basaloid squamous cell carcinoma (BSCC), poorly differentiated squamous cell carcinoma (PDSCC), and well to moderately differentiated squamous cell carcinoma (W/MSCC) of the oral cavity.

Design: Retrospective cohort.

Setting: Referral tertiary center.

Patients: Seventeen patients with primary oral BSCC, 27 with PDSCC, and 27 with SCC.

Intervention: The 71 patients all had surgery and 52 had postoperative radiotherapy.

Main outcome measures: Recurrences and survival.

Results: The median follow-up time was 52.4 months for patients with BSCC, 22.2 months for those with PDSCC, and 13.8 months for those with SCC. No statistically significant differences on survival were found among the BSCC, PDSCC, and SCC groups. The 5-year cancer-specific survival rates were 50% for patients with BSCC, 37% for those with PSCC, and 49% for those with W/MSCC (P =.71); the 5-year overall survival rates were 46% for patients with BSSC, 18% for those with PSCC, and 41% for those with W/MSCC (P =.25). Disease-free survival was not significantly different among the BSCC, PSCC, and W/MSCC groups (P =.57). The 5-year rate of disease-free survival was 40% for patients with BSCC, 37% for those with PSCC, and 53% for those with W/MSCC.

Conclusions: The clinical course of BSCC is similar to the courses of PSCC and W/MSCC when clinical T and N classifications are matched. Prognosis does not differ for patients with BSCC of the oral cavity and those with conventional oral squamous cell carcinomas PSCC and W/MSCC.

PubMed Disclaimer

Publication types